ANUZEGO Trademark

Trademark Overview

On Monday, January 14, 2013, a trademark application was filed for ANUZEGO with the United States Patent and Trademark Office. The USPTO has given the ANUZEGO trademark a serial number of 85822521. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 4, 2017. This trademark is owned by Novartis AG. The ANUZEGO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in hematology, in oncology, in tissue and organ transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; Pharmaceutical preparations for human use, namely, anti-infectives, pharmaceutical preparations for human use for treating bacterial-based diseases, antivirals, antibiotics, and antifungal preparations
anuzego

General Information

Serial Number85822521
Word MarkANUZEGO
Filing DateMonday, January 14, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 4, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 3, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in hematology, in oncology, in tissue and organ transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; Pharmaceutical preparations for human use, namely, anti-infectives, pharmaceutical preparations for human use for treating bacterial-based diseases, antivirals, antibiotics, and antifungal preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 18, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Tuesday, September 5, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 4, 2017ABANDONMENT - NO USE STATEMENT FILED
Friday, February 24, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 23, 2017EXTENSION 5 GRANTED
Thursday, January 26, 2017EXTENSION 5 FILED
Tuesday, February 21, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 26, 2017TEAS EXTENSION RECEIVED
Tuesday, August 9, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, August 6, 2016EXTENSION 4 GRANTED
Monday, July 25, 2016EXTENSION 4 FILED
Monday, July 25, 2016TEAS EXTENSION RECEIVED
Thursday, February 11, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 10, 2016EXTENSION 3 GRANTED
Tuesday, January 26, 2016EXTENSION 3 FILED
Friday, February 5, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 26, 2016TEAS EXTENSION RECEIVED
Thursday, August 13, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 12, 2015EXTENSION 2 GRANTED
Friday, July 24, 2015EXTENSION 2 FILED
Monday, August 10, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 24, 2015TEAS EXTENSION RECEIVED
Wednesday, January 28, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 26, 2015EXTENSION 1 GRANTED
Monday, January 26, 2015EXTENSION 1 FILED
Monday, January 26, 2015TEAS EXTENSION RECEIVED
Tuesday, July 29, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 3, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 3, 2014PUBLISHED FOR OPPOSITION
Wednesday, May 14, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 1, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 28, 2014ASSIGNED TO LIE
Wednesday, April 9, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 9, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 9, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 9, 2014TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, October 22, 2013NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, October 22, 2013FINAL REFUSAL E-MAILED
Tuesday, October 22, 2013FINAL REFUSAL WRITTEN
Friday, October 11, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 10, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 10, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 29, 2013NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, April 29, 2013PRIORITY ACTION E-MAILED
Monday, April 29, 2013PRIORITY ACTION WRITTEN
Friday, April 26, 2013ASSIGNED TO EXAMINER
Friday, January 18, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 17, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

anuzego system preparations disorders pharmaceutical treatment human diseases prevention anti namely